Healthcare Market Research Report By MRFR: May 2020

Friday, May 29, 2020

Embolization Particle Market Analysis to Witness Increase in Revenues by 2023

Embolization Particle Market Information: By Product Type (Radioembolization & Drug Eluting Beads), Application, (Oncology, Peripheral Vascular Disease, Neurology), Level of Occlusion (Proximal) End User (Hospitals & Clinics) – Global Forecast till 2023

Market Research Future (MRFR), in its recently published market forecast asserts that the global Embolization Particle Market Analysis will register a striking CAGR of 9.64 % throughout the forecast period (2017 – 2023) garnering accruals of USD 1,909.76 Mn. by 2023.

Embolization Particle is a minimally invasive therapy used in many procedures as a part of interventional radiology. Embolization is used to stop bleeding as well as to treat tumors that cannot be removed by surgery by stopping its blood supply. The invention of Embolization Particle in therapeutics has offered some exciting possibilities. While Embolization can also be used with ablation, it may not be a good option for some patients whose liver has been damaged by diseases such as cirrhosis or hepatitis.

The use of Embolization in the field of medicine as a whole has revolutionized the way of diagnosis, treatment, and prevention. Hence, the market for Embolization Particle is blooming currently, with the growing prevalence of cases of tumors. The augmenting demand for noninvasive therapies predominantly drives the market growth.

Also, growing incidence of cancer and other metabolic diseases have fueled the growth of Embolization Particle market. Additional factors contributing to the market growth include the growing population, urbanization and improving economic conditions that are increasing access to the quality healthcare and quality of life of people.

On the other hand, unavailability of interventional neuroradiologists and interventional neuroradiology (INR) labs along with the lack of regulatory standards in the examination of Embolization Particle and higher cost of the treatment are some of the key factors impeding the market growth.

Nevertheless, constant technological development, increasing demand for the better treatment, along with the governmental support is expected to foster the market growth commutatively.

Global Embolization Particle Market Segmentation

Global Embolization Particle Market is segmented into five key dynamics for the convenience of understanding;

By Product Types : Radioembolization and Drug Eluting Beads among others.

By Applications : Oncology, Peripheral Vascular Disease, and Neurology among others.

By Levels of Occlusion : Proximal and Distal among others.

By End-Users : Hospitals, Clinics and ambulatory services among others.

By Regions : North America, Europe, APAC and Rest-of-the-World.

The Radioembolization segment accounted for the largest market share in 2016 and is estimated to grow at 10.01% CAGR approx. during the forecast period from 2017-2023.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/4815

Global Embolization Particle Market Regional Analysis

Globally North America leads the Embolization Particle market with the significant market share. The Market is expected to grow phenomenally from 2017 to 2023. Factors substantiating the market growth include the growing number of patients suffering from tumors coupled with the high healthcare expenditures, significant developments in the healthcare domain, and focus of research institutions on advent technologies for new and advanced diagnosis and treatment methods. Well-defined per capita healthcare expenditure is undoubtedly a key driving force behind the market growth in the region.

Moreover, the growing number of centers offering embolization particle therapy coupled with the availability of advanced infrastructures & devices, and availability of skilled healthcare professional contributions to the market growth in the region. The region is expected to reach the valuation of USD 703.13 Mn. by 2023.

The US, backed by the technological advances and availability of funding for the development of new therapeutics and treatment accounts for the major contributor to the market growth. Moreover, the presence of the well-established players also drives the market for Embolization Particle in this region.

Europe emerging as a lucrative market for Embolization Particle will expand with a phenomenal CAGR. The resurging economy in the region is expected to foster the regional market growth. Besides, availability of technologically advanced devices and the proliferation of quality healthcare along with the increasing healthcare cost mushrooms the growth of the market in the region.

Moreover, the accessibility of technology and increasing government support for the research and development support the market growth in the region. Also, factors such as the increasing prevalence of cancer among the population due to the changing lifestyle and the growing emphasis on rapid diagnosis and treatment of cancer substantiate the growth of the market in this region.

Asia Pacific market for the Embolization Particle is expected to perceive the fastest growth by 2023 registering a CAGR of 10.11% from 2017 to 2023. India and China backed by the huge population, and the availability of low-cost therapies will lead the regional market. Moreover, the fastest growing healthcare sector coupled with the large unmet needs over the forecast period will provide impetus to the market growth.

Vietnam, Thailand, and Malaysia among other South East Asian countries are projected to contribute significantly to the regional market growth. Besides the growing penetration of healthcare insurance along with the increase in the demand for various diagnosis & treatment methods, is expected to drive the Embolization Particle market in the in the Asia Pacific region.

Global Embolization Particle Market Competitive Analysis

Key Players are actuated to bring innovations in the therapy with minimum adverse effects, as well as to target emerging applications to leverage growth opportunities. They are focusing on R&D in order to develop the therapy further.

Key Players:

Market players driving the global embolization particle market include Guerbet, Boston Scientific Corporation, BTG International Ltd, Sirtex, Medtronic, Merit Medical, and Terumo. Profiling them in its analysis MRFR finds the strategies helping them to stay at the forefront of competition.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Absorbable Heart Stent Industry Size, Share, Historical Growth, Analysis, Development Status, Opportunities and Forecast To 2025

Absorbable Heart Stent Market Research Report: Information by Material (Metal and Polymer), Application (Coronary Artery Disease and Periphery Artery Disease), End-Use (Hospitals and Clinics, Cardiovascular Centers, Research Institutes and Organizations and Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025

Market Analysis

The Global Absorbable Heart Stent Industry is predicted to grow at a 9.6% CAGR between 2017-2023, states the latest Market Research Future (MRFR) report. Absorbable Heart stents are meant for patients with relatively noncomplex blockages and low risk. It gets dissolved in the body with time and its possible advantages include fewer risks compared to traditional metal stents and reduced repeat procedures. Absorbable stents are generally made of polymers or metals. The metallic stents are generally made of iron and its alloys, iron, magnesium, and zinc. Of the two, the polymeric stents are widely used for their ability to maintain a strong scaffold.

Various factors are propelling the absorbable heart stent market growth. Some of these factors, as per the latest Market Research Future report, include increasing psychological and physical stress, changing lifestyle, rising number of cardiac procedures, rise in patient pool, and burgeoning demand for absorbable heart stents. Additional factors propelling the absorbable heart stent market growth include technological advancements in heart stents, rising incidence of cardiac diseases, lack of physical exercise, and increasing unhealthy habits.

On the contrary, the high cost of cardiac surgery and the price of stents in some developed countries are factors that may hamper the absorbable heart stent market growth during the forecast period.

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the absorbable heart stent market on the basis of end use, application, and material.

By material, the absorbable heart stent market is segmented into polymer and metal. Of these, the polymer segment will lead the market over the forecast period owing to the rising applications as well as the use of stents that are polymer-based.

By application, the absorbable heart stent market is segmented into periphery artery disease and coronary artery disease. Of these, the coronary artery disease segment will dominate the market over the forecast period due to the increasing incidence of coronary diseases in geriatric individuals.

By end use, the absorbable heart stent market is segmented into research institutes and organizations, cardiovascular centers, hospitals and clinics, and others. Of these, hospitals and clinics will have the maximum share in the market during the forecast period owing to the increasing risk of peripheral artery disease and coronary artery disease coupled with a growing number of heart surgeries.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/1175

Regional Analysis

By region, the absorbable heart stent market report covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, Europe, and the Asia Pacific. Of these, the Americas will spearhead the absorbable heart stent market during the forecast period. Factors pushing the growth of the absorbable heart stent market in the region include increasing use of absorbable heart stents by healthcare physicians, preference of patients for minimally invasive therapies, increasing prevalence of chronic diseases, and favorable initiatives undertaken by the government for healthcare reforms. Canada and the US are the chief contributors in this region owing to the rising geriatric population suffering from obesity and diabetes, greater healthcare penetration, good reimbursement rates, and the presence of good hospitals, especially in the developed countries of the region.

In Europe, the absorbable heart stent market is predicted to have the second-largest share during the forecast period. Factors pushing the growth of the absorbable heart stent market in the region include the prevalence of peripheral artery disease (PAD) and coronary artery disease CAD), a huge patient pool, increasing healthcare penetration, and expanding medical devices industry. Germany is the main contributor in this region owing to the presence of a huge medical device industry, followed by France.

The absorbable heart stent market in the APAC region is predicted to experience faster growth during the forecast period. Factors pushing the growth of the absorbable heart stent market in the region include increasing incidence of chronic diseases, especially cardiovascular disease, large unmet needs, growing healthcare sector, and development of healthcare infrastructure. China, as well as India, are the chief contributors in this region.

The absorbable heart stent market in the MEA is predicted to have a substantial growth owing to the increasing use of surgical treatments for cardiovascular diseases.

Key Players

Notable players profiled in the absorbable heart stent market report include Meril Life Sciences Pvt. Ltd, Terumo Medical Corporation, Medtronic, Boston Scientific Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Braun Melsungen AG, Elixir Medical Corporation, REVA Medical, Inc., Biotronik, and Abbott Laboratories. Key players have incorporated different strategies to create a niche in the market, such as joint ventures, research, and development activities, collaborations, expansions, mergers and acquisitions, and more.

Pediatric Medical Device Industry insights to Witness Exponential Growth by 2025

Pediatric Medical Devices Market Research Report: Information by Product [Cardiology Devices, In Vitro Diagnostic (IVD) Devices, Diagnostic Imaging Devices, Telemedicine, Anesthesia and Respiratory Care Devices, Neonatal ICU Devices, Monitoring Devices and others], End User (Hospitals, Pediatric Clinics, Ambulatory Surgery Centers, Research and Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025

The global Pediatric Medical Device Industry insights is growing pervasively, mainly due to the innovations and new technologies. The emergence of futuristic pediatric medical devices has revolutionized the childcare completely. What lightning does to mushrooms, advancements in technology are doing to the Pediatric Medical Device Market Size, allowing it to flourish lavishly.

Besides, increasing regulatory approvals and issued patents are accelerating the growth of the market. According to Market Research Future (MRFR), the global Pediatric Medical Device Market Size is expected to garner exponential accruals by 2023. In its recently published research, MRFR also asserts that the market would register a CAGR of over 10.5% throughout the forecast period (2017-2023).

Countries across the globe have become extremely responsive towards child healthcare, which is a key driving force behind the growth of the market. There are substantial funding programs from the governments, delving into the financial, regulatory, and design constraints associated with the developments of these devices.
Also, public and private sectors make considerable investments to drive challenging endeavors of R&D for the development of pediatric medical devices, treatments, and overall healthcare. The successful combination of information technology (IT) and healthcare catalyzes the overall growth of the market.

On the other hand, lack of funds and stringent & unclear regulatory framework, alongside, the growing data security are impeding the market growth, especially in underdeveloped and developing regions. Nevertheless, favorable reimbursement policies, along with the ongoing product developments & commercialisations would support the market growth to an extent.

Global Pediatric Medical Device Market Size   – Segments The report is segmented into three dynamics to widen the scope of understanding,
By Device Type         : Infant Caps, New-born Hearing Screener, Cranial Orthosis, Infant Warmer, Incubators, and Bililights, among others.
By End-users                         : Hospitals & Clinics, Pediatrician & Doctors, among others.
By Regions                : Europe, North America, APAC, and the Rest-of-the-World (RoW).

Global Pediatric Medical Device Market Size – Regional Analysis
North America dominates the global Pediatric Medical Device Market Size with a significant market share. The region owns superior medical facilities and flourishing medical device sectors, which impact the market growth, positively. Moreover, the rising prevalence of juvenile diabetes and chronic diseases related to heart, digestive, and kidney health among adolescents foster regional market growth.
Besides raising awareness about adolescent health is creating a massive demand for medical devices in pediatric hospitals and clinics. Factors such as huge technological advancements and the enormous uptake of advanced medical devices led by the high per capita healthcare expenditures are commutatively impacting the market growth, to an extent.
The US market, led by the rising obesity disorder among children accounts for a significant share in the North American Pediatric Medical Device Market Size. Furthermore, well-established healthcare infrastructures, specially designed for childcare with their skilled professionals & doctors, are pushing up the market growth in the region.
Europe stands second in the global Pediatric Medical Device Market Size, flowing the North American market closely. The resurging economy in this region acts as a major tailwind behind the regional market growth, availing the best possible child healthcare and increasing healthcare expenditures. Additionally, government support fosters market growth in the region, encouraging the manufacturers to develop new and better devices.
The Pediatric Medical Device Market Size in the Asia Pacific region has emerged as a lucrative market globally. Factors such as the high birth rate and rapidly improving healthcare infrastructure in the APAC region are influencing the market growth, positively. Furthermore, the rapidly growing markets in India and China are expected to provide immense opportunities for the growth of pediatric medical devices.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/980

Competitive Landscape

The presence of several notable players intensifies the competition in the already highly competitive and diversified market. These players manage to gain a substantial market share by driving R&D activities required for the development of new devices and technologies.
They also invest continually to incorporate strategies such as mergers & acquisitions, collaboration, expansion, and new product/technology development. They tap the emerging markets in developing regions to expand their business further. They compete with each other based on product reliability, quality, cost, and aftermarket services.

Major Players:
Players leading the global Pediatric Medical Device Market Size include Abbott (US), General Electric Company (US), Johnson & Johnson Private Limited (US), Medtronic (Ireland), Siemens AG (Germany), Koninklijke Philips NV (Netherland), Novamed (US), Phoenix Medical Systems USA (US), Phoenix Medical Systems (P) Ltd. (India), and Pega Medical (US), among others.

Allergy Skin Test Market Trends, Size, Analytical Overview, Growth Factors, Demand and Trends Forecast to 2023

Allergy Skin Test Market Information: By Type (Prick, Intradermal, Patch), Indication (Allergy Rhinitis, Allergic Asthma, Drug Allergy, Anaphylaxis, Urticarial, Food Allergy), End User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast till 2023

Allergies are medical conditions triggered by reactions to various substances such as pollen, dust, weeds, and others. They are physically characterized by spots on the skin, coughing, and other symptoms. Allergy skin tests are a trustworthy option for ascertaining the presence of allergies in a patient. The global allergy skin test market report by Market Research Future (MRFR) lists out drivers, trends, and challenges in a detailed and comprehensive manner.

Market Overview

The Global Allergy Skin Test Market Trends is touted to attain a significant valuation at a CAGR of 8.2% during the forecast period (2017-2023). High reported cases of allergies such as asthma, allergic conjunctivitis, and rhinitis is one of the primary drivers of the market. According to the World Health Organization (WHO), close to 40 million cases of allergies related to inhalation have been reported in 2012. Large number of patients with allergies due to consumption of drugs and massive demand for allergy tests are other drivers expected to augur well for the market growth.

Availability of diagnostics and therapeutics at major hospitals is estimated to widen the scope of the market till 2023. Accuracy and reliability of these tests can foster the market growth. Change in lifestyles, poor dietary habits, increasing levels of indoor and outdoor pollution, and rapid urbanization can influence the market growth. Introduction of specific allergen in the tests to enhance its accuracy can do wonders for the global allergy skin test market.

Segmentation

The global allergy skin test market is segmented by type, indication, and end-user.

By type, it is segmented into patch, intradermal, prick, and others.

By indication, it is segmented into urticarial, anaphylaxis, allergy rhinitis, allergy conjunctivitis, drug allergy, and others.

By end-user, it is segmented into diagnostic centers, hospitals & clinics, and others.

Regional Analysis

The Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and the Americas are the main regions considered during the compilation of the market report.

Europe is the biggest and most lucrative region for the global allergy skin test market due to prevalence of anaphylaxis and demand for rapid diagnostic services. The market will thrive due to high cases of allergies being reported. As per European Academy of Allergy and Clinical Immunology, nearly 150 million in the European Union (EU) suffer from some form of allergic disease.

The Americas held close to 30% market share in 2016. It can experience a massive upheaval in demand due to rise in the cases of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, eczema, food allergy, and allergic asthma are the most common types found in the region. The availability of technologically advanced tests to ascertain their presence at a preventive stage can bode well for the market.

The APAC region can display a strong CAGR during the forecast timespan due to high prevalence of allergic asthma due to rise in pollution levels. Other factors which can influence the sales of allergy skin tests are availability of portable devices and mobile applications which can lower the price of the product by a considerable degree. Presence of minimally invasive diagnostic techniques, unmet patient needs, and improvement in the healthcare infrastructure can bode well for the market growth.

The MEA region can exhibit a modest rise in demand for allergy skin tests due to high incidence of chronic respiratory diseases.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/4630

Competition Outlook

Lincoln Diagnostics, Inc., Cell Science Systems, Novartis Global, Quest Diagnostics Incorporated, HollisterStier Allergy, Thermo Fisher Scientific, and Arlington Scientific, Inc., are prominent names in the global allergy skin test market. Innovation in products and services as well as changes in the supply chain are taken into consideration by these players for accelerating the production rate and getting the product faster to clients.

Industry News

The Colourstart test has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. to be sold for teens starting from the age of 16. The test contains two skin patches which can be used to discern an allergic reaction to hair dye which contains the chemical, paraphenylenediamine (PPD).

Menopause Treatment Market Growth: Overview by Types, Application, Key Players, Regional Outlook, Market Drivers & Restraints 2023

Menopause Treatment Market Information: By Hormonal Treatment (Estrogen, Progesterone, Combination), Non-Hormonal Treatment (Anti-Depressants, Anti-Anxiety, Anti-Migraine), End-User (Hospitals & Clinics, Academia & Research) – Global Forecast Till 2023

The global menopause treatment market is expected to exhibit a solid 4.2% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The Global Menopause Treatment Market Growth is examined in detail in the report, which presents a comprehensive overview of the market’s historical growth trajectory, present stats, and future growth potential. The leading drivers and restraints affecting the global menopause treatment market are also profiled in the report, leading to the readers being given a comprehensive outlook of the key factors affecting the market’s movement.

Menopause is a natural stage in a woman’s life in which reproductive hormones start to be produced less and less, leading to a loss of a woman’s ability to conceive and a raft of other related physiological changes. Most people know about hot flashes as being symptomatic of menopause, and indeed hot flashes are among the most conspicuous effects of menopause. However, menopause also causes other changes in joint health and other vasomotor symptoms. This has resulted in a growing demand for medication to treat these conditions.
The growing demand for personalized medication to beat menopause symptoms and effects is likely to be a key driver for the global menopause treatment market. As awareness about menopause treatment is rising, more and more women are adopting the medication into their everyday lives, making themselves capable of facing the physiological changes caused by menopause and remaining functional well into their old age. The increasing demand for natural medication is also likely to be a major driver for the global menopause treatment market, with studies showing that several women prefer natural medication over artificial hormone replacement therapy.

Competitive Analysis:
Leading players in the global menopause treatment market include Teva Pharmaceutical Industries Ltd., Cipla Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., Allergan plc, Pfizer Inc., Novo Nordisk A/S, Novartis AG, and Merck & Co. Inc. Other players are also likely to enter the menopause treatment market in the coming years, as the commercial scope of the menopause treatment market is increasing all the time, giving more opportunities for players in the healthcare sector. Leading players in the global menopause treatment market are likely to focus on product expansion in the coming years, with personalized medicine being a major factor in the market in the coming years.

A new survey released in October 2019 by Maryon Stewart, founder of the Women’s Nutritional Advisory Service, showed that 40% of women facing menopausal symptoms choose not to avail medical services, while 9 out of 10 who do use the prescribed medication prefer natural alternatives to hormone replacement therapy, or HRT.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/4579

Segmentation:
The global menopause treatment market has been segmented on the basis of hormonal treatment, non-hormonal treatment, end user, and region.
Based on the hormonal treatment, the market has been segmented as estrogen, progesterone, combination of the two and other. Estrogen holds the leading share of 41% in the global menopause treatment market, followed by progesterone.
Based on the non-hormonal treatment, the market has been segmented as anti-depressants, anti-anxiety, anti-migraine and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Regional Analysis:
The Americas account for the dominant share in the global menopause treatment market, followed by Europe. Widespread awareness about menopause and the wide range of treatments available to ward off the symptoms of the same is the major driver for the menopause treatment market in the developed western world. The growing geriatric population in these regions has driven the menopause treatment market, as the patient population is likely to grow even further over the forecast period. The UK is a leading regional market within Europe, followed by Germany and France.

Asia Pacific is also likely to be an important regional market for menopause treatments in the coming years, with India and China leading the regional market’s charge over the forecast period.

Endoscopy Device Market Size: In-Depth Analysis on Market Dynamics, Segmentation & Emerging Growth Factors 2023

Endoscopy Device Market Growth And Trends Analysis By Type, (Flexible Endoscopes), Therapy (Gastroscopy), Treatment & Procedure (Abdominal, Gynecologic And Pelvic Organ Conditions), Application, (Gastrointestinal Endoscopy), Accessory & Processor, Technology, And End User – Global Forecast Till 2023
The Endoscopy Device Market Size is growing pervasively, mainly due to the technological advances that have improved the performances of these devices. Besides, factors such as increasing funding & reimbursement for screening & treatment with endoscopic techniques are promoting the endoscopy device market growth. Moreover, the growing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and obstetrics/gynecology diseases escalates market growth to furthered height.
According to Market Research Future (MRFR), the global endoscopy device market is poised to reach USD 42,342.4 MN by the end of 2023. In its recent endoscopy device market forecast, MRFR also asserts that the market would register a 6.3% CAGR throughout the review period (2017 – 2023). Additionally, well-spread awareness towards the availability and benefits of endoscopy devices are substantiating the market growth.
Market Drivers and Restraints:
Drivers:

Rising demand for effective diagnostic & therapeutic options.
Shift towards less invasive treatment methods.
Increasing geriatric population.

Restraints:

Infections and complications caused by endoscopy devices.
High cost of endoscopy devices.
Lack of knowledge about the availability & benefits of endoscopy devices.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/1967
Global Endoscopy Device Market – Segments
The analysis has been segmented into six main dynamics to widen the scope of understanding,
By Type            : Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopes, Robot-Assisted Endoscopes, Surgical Endoscopes, and other Endoscopes.
By Therapy: Colonoscopy, Arthroscopy, Gastroscopy, Laparoscopy, Endoscopic Retrograde Cholangiopancreotography, Sigmoidoscopy, Cholangiopan Creotography, Ureteroscopy, Cystoscopy, and others.
By Treatment & Procedure: Abdominal, Gynecologic & Pelvic Organ Conditions, Joint & Orthopedic Conditions, Lung & Airway Conditions, Lower Gastrointestinal Conditions, Upper Gastrointestinal Conditions, Urinary System Conditions, and others.
By Application              : Gastrointestinal Endoscopy, Arthroscopy, Obstetrics/Gynecology Endoscopy, Urology Endoscopy, Bronchoscopy, Mediastinoscopy, Otoscopy, and others.
By End-User   : Critical Care, Gastroenterologists, General & Pediatric Surgeons, Obstetricians-Gynecologists (ob/gyns), Orthopedic Surgeons, and others.
By Regions                     : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.
Global Endoscopy Device Market – Regional Analysis
North America dominates the global endoscopy device market. The largest share of the market attributes to the strong economic conditions, massive development in the healthcare domain, and the focus of research institutions on updating technology for new & advanced diagnosis & treatment methods. Moreover, factors such as the presence of advanced hospital infrastructures and skilled healthcare professionals are increasing the region’s endoscopy device market share in the global market. The North American endoscopy device market is estimated to retain its leading position throughout the assessment period.
Europe stands second in the global endoscopy device market, heading with the increasing emphasis on rapid diagnosis & treatment of cancer and gastrointestinal diseases. Besides, factors such as the rising government support for R&D activities and growing focus on the development of new devices in the region are contributing to endoscopy device market growth. Driven by the growing numbers of specialty services offered by various healthcare providers, the European endoscopy device market is likely to grow at a significant CAGR during the review period.
The Asia Pacific endoscopy device market is rapidly emerging as a promising market globally. Rapidly developing countries like India and China are encouraging the growth of the regional market. Furthermore, the increasing patient population of cancer and gastrointestinal diseases is creating a vast market demand for various diagnosis & treatment methods. Moreover, the augmenting demand for quality devices, proliferating healthcare technology, and increasing uptake of endoscopy devices in the region are providing impetus to market growth. The APAC endoscopy device market is estimated to register a phenomenal CAGR throughout the analysis period.
Global Endoscopy Device Market  – Competitive Analysis
Highly competitive, the endoscopy device market appears to be diversified with the presence of a large number of players. These players make substantial investments in R&D to drive innovations and strategic initiatives. To gain a larger competitive advantage in the market, players adopt strategies such as mergers & acquisitions, expansion, collaboration, and product launch. To increase their global footprints, players acquire small yet promising companies from the emerging markets.
They compete against each other based on the quality, reliability, and cost of the devices. Looking at the huge demand for innovative technologies that can help clinicians to provide the best possible treatments to the patients in need, manufacturers create unique solutions that can meet the challenging needs of consumers. They work with physicians, nurses, and technicians around the world, which further helps them to identify unaddressed needs.
Major Players:
Players leading the endoscopy device market include Integrate Endoscopy, Cogentix Medical, J&J services Inc, Interscope Inc., Shaili Endoscopy, Cantel Medical, Cognetix, Micro-Tech Endoscopy, Stryker, Karl Storz Gmbh & Co. KG, Olympus, Fujifilm, Richard Wolf, and Pentax Medical, among others.
Industry/Innovation/Related News:
January 16, 2020 — Hoya Corp. (the US), a subsidiary Pentax Medical, announced the FDA 510(k) clearance for its Imagina endoscopy system, launching the device in the U.S. The Imagina system is designed to perform gastrointestinal procedures at ambulatory surgery centers (ASCs). The Imagina i10c series is the only endoscope platform with a real-time, digital image enhancement system that offers an enhanced view of the texture of the mucosal surface and blood vessels.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Bile Duct Cancer Market Size, Share, Historical Growth, Analysis, Development Status, Opportunities and Forecast To 2023

Bile Duct Cancer Market Research Report, By Type (Intrahepatic, Extrahepatic), Diagnosis (Blood Tests, Abdominal Imaging, Surgery), By Treatment (Chemotherapy, Radiotherapy), By End User (Hospital& Clinics, Academic Institutes) - Global Forecast till 2023

Market Analysis

The global Bile Duct Cancer Market is likely to grow at a 9.2% CAGR between 2017- 2023, according to the recent Market Research Future (MRFR) report. Bile duct cancer is a form of cancer that occurs in the slender tubes which carry bile through the liver. It is a rare yet aggressive type of cancer. Some of its symptoms include nausea and vomiting, fever, loss of appetite, weight loss, abdominal pain, dark urine, light-colored stools, jaundice, and intensely itchy skin.

Various factors are adding to the global bile duct cancer market share. These factors, as per the new MRFR report, include increasing cases of bile duct cancer, rising healthcare expenditures, rising awareness of bile duct cancer, increasing investments in the research and development activities for treatment procedures, and technological advances in the healthcare sector.

On the contrary, high treatment costs, long duration in drug approvals, low healthcare expenditure, and related side effects are factors that may limit the bile duct cancer market growth over the forecast period.

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global bile duct cancer market based on end users, type, treatment, and diagnosis.

By type, the bile duct cancer market is segmented into extrahepatic, intrahepatic, and others.

By diagnosis, the bile duct cancer market is segmented into surgery, abdominal imaging, blood tests, and others. The abdominal imaging segment is again segmented into magnetic resonance cholangiopancreatography (MRCP), percutaneous transhepatic cholangiography (PTC), endoscopic retrograde cholangiopancreatography (ERCP), and others.

By treatment, the bile duct cancer market is segmented into radiotherapy, chemotherapy, and others. The chemotherapy segment is again segmented into cisplatin, gemcitabine, 5-fluorouracil, and others. Of these, the 5-fluorouracil segment will lead the market over the forecast period.

By end users, the bile duct cancer market is segmented into research organizations, academic institutes, hospitals and clinics, and others. Of these, the hospitals will have lions share over the forecast period.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4741

Regional Analysis

Based on the region, the global bile duct cancer market covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period. Factors adding market growth include the presence of a well-established healthcare industry, increasing healthcare expenditure, a rising number of patients, and rising cases of bile duct cancer. Additional factors adding market growth include growing public-private investments, increasing awareness programs, and ongoing research activities. Canada & the US are the key contributors in the region for the rising cases of bile duct cancer.

The global bile duct cancer market in Europe is predicted to hold the second-largest share over the forecast period. Factors boosting the market growth include government support for R&D, huge patient population, and availability of funds for research. Additional factors adding market growth in the region include technological advances, advanced healthcare facilities, and the presence of developed economies.

The global bile duct cancer market is the APAC region is predicted to grow at a quick face over the forecast period. Factors fuelling the market growth in the region include the presence of key suppliers and manufacturers of bile duct cancer drugs, increasing fiscal investments by government, increasing cases of liver infections, and huge patient population pool. China, as well as India, are the key contributors in the region.

The global bile duct cancer market in the MEA is predicted to have the smallest share over the forecast period for the presence of a poor economy, particularly in the Africa region. The Middle East will have a good share in the market for the huge healthcare expenditure & the presence of a well-established healthcare sector.

Key Players

Leading players profiled in the global bile duct cancer market report include Mylan N.V. (U.S.), Fresenius Kabi AG (Europe), Sanofi (Europe), Eli Lilly and Company. (U.S.), Teva Pharmaceutical Industries Ltd. (Middle East), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Europe), and Pfizer Inc. (U.S.).

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Tumor Ablation Market: Historical, Current and Projected Market Size, Competitive landscape & Forecast 2023

Tumor Ablation Market: Information by Technology (Radiofrequency, Microwave), Treatment (Surgical, Percutaneous), Application (Liver cancer, Lung cancer), By End User (Hospital, Surgical and Ablation Centers) - Global Forecast Till 2023

Overview:

The global Tumor Ablation Market is proceeding towards a substantial valuation with 12.8% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) revealed several factors in the process that can impact the market outcome in the coming years.

Factors like the rising prevalence of cancer are playing a crucial role in taking the market forward. On the other hand, better expenditure for research works, the inclusion of top-class technologies, and others are expected to boost the market prospect. In developed countries, advanced technologies are making the procedure easier. In developing countries, scopes for expansion are getting better with revamping the healthcare sector.

However, the cost associated with the procedure may create obstacles for further market growth.

Segmentation:

The global tumor ablation market, as per the MRFR analysts, has been segmented with a special focus on technology, application, treatment, and end-user. This creates scope for better market understanding as it reveals insights based on a detailed study of factors, dynamics, and demographic changes.

By technology, the study on the tumor ablation market has been segmented into the microwave, cryoablation, irreversible electroporation, radiofrequency, and others. The microwave segment is getting traction from several research teams.

By treatment, the global market for tumor ablation can be studied on the basis of percutaneous, surgical, and laparoscopic.

By application, the global study on tumor ablation can be segmented on the basis of lung cancer, breast cancer, liver cancer, prostate cancer, bone cancer, and others. Growing prevalence of cancer can promote the use of the system.

By end-user, the study related to the tumor ablation market has been segmented into surgical and ablation centers, hospitals, and research institutes. Growing number of surgical and ablation centers are expected to boost the market presence.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/7139

Regional Analysis:

The Americas would lead the market with their rising inclusion of latest technologies, better healthcare structure, the influx of investment, and others. The US and Canada would influence the regional market. However, the presence of poor economies in Southern America can make the growth a bit sluggish. In Europe, government investment in research works and boosts from various healthcare schemes are expected to impact the market. In the Asia Pacific region, this growth would gain precedence in China, Japan, Singapore, India, and others.

Competitive Landscape:

The global market for tumor ablation can benefit from various companies like EDAP TMS, Misonix Inc., SonaCare Medical, Medtronic Plc., Healthtronics Inc., Neuwave Medical, Inc., AngioDynamics Inc., Biotronik, Galil Medical, Inc, Boston Scientific Corporation, and Covidien PLC. These companies are known for their superlative performances in the sector where they use myriad opportunities to boost their market presence and expand their operations. These opportunities are often triggered by various mergers, acquisitions, and collaborations. These opportunities also get backed by a hike in investment for research and development that increases the chance of new product launches and provides scope for better market presence. MRFR recorded these moves to understand how the market would proceed in the coming years.

Industry News:

In May 2020, researchers revealed that the MedWaves AveCure microwave ablation procedure is now getting high traction in treating people with a brain tumor. The recent treatment of a patient in Guadalajara, Mexico, is a successful example of the procedure owing to which the company is now expecting a better thrust for the product from institutes across the world. The MRI post-operation shows a significant reduction in the size of the tumor and doctors are suggesting that the patient can now resume his regular activities with minor symptoms.

Chronic Kidney DIisease Market Covering Competitive Scenario & Market Dynamics throughout 2018-2023

Chronic Kidney Disease Market Research Report: By Diagnosis (Blood Test, Urine Test, Biopsy), by Treatment (Drugs, Dialysis, Kidney Transplant), by Indication (Type 1 or Type 2 Diabetes, High Blood Pressure), End-User (Hospitals) - Global Forecast Till 2023

Overview:

The global report on the Chronic Kidney Disease Market suggests a good hike in the revenue during the forecast period of 2018 to 2023. Market Research Future (MRFR) reveals various factors that can impact the market outcome in the coming years, like an increasing number of biopsy procedures, the inclusion of new technologies in the healthcare sector, market competition to develop better products and edge out rivals, hike in research investment, and others. However, in some cases, the high cost associated with procedures can deter the market from having good growth.

Segmentation:

The global report on the chronic kidney disease market has been studied by MRFR experts after getting it segmented on the basis of indication, diagnosis, treatment, and end-user. This recording of segments is backed by a close study of various factors and demographic challenges that would help the market in developing strategies with better possible impacts.

By diagnosis, the report contains details of the chronic kidney disease market with segmentation into urine tests, imaging tests, blood tests, and kidney biopsy. The imaging test segment is getting traction for its ability to provide certainty regarding the process.

By treatment, the market report has been segmented into dialysis, drugs, and kidney transplant. The drugs segment has been segmented into angiotensin-ii receptor blockers, ace inhibitors, beta-blockers, calcium channel blockers, and erythropoiesis-stimulating agents.

By indication, the report on the chronic kidney disease market includes segments like high blood pressure, polycystic kidney disease, Type 1 or Type 2 diabetes, and others. Growing number of diabetes patient is spurring the demand for type 1 or type 2 diabetes segment.

By end-user, the global market report on chronic kidney disease has been segmented into diagnostic centers, hospitals and clinics, and others. The hospitals and clinics segment has been getting thrust from the market for its ability to address the disease with better infrastructure is higher than other parts.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/5744

Regional Analysis:

North America has the chance to lead the market as the expenditure for the healthcare sector is high in the region. This is primarily due to the superlative healthcare setup and improved reimbursement policies that help more patients in going for a check-up. On the other hand, the presence of countries like the US and Canada are expected to boost the regional market. In Europe, market growth would get backed by countries like the UK, Italy, France, Germany, and others. In the Asia Pacific region, growth would be backed by emerging nations and their revamped healthcare industry.

Competitive Analysis:

The global market for chronic kidney disease market depends on the strategic moves made by companies like Beckman Coulter, Abbott, Siemens, Sysmex, ACON Laboratories, Inc., F. Hoffmann-La Roche Ltd, ARKRAY, OPTI Medical, URIT Medical, Nova Biomedical, Teva Pharmaceutical Industries Ltd., 77 Elektronika, Randox Laboratories, Pfizer Inc., AbbVie Inc., Amgen Inc., AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Sanofi S.A., and Kissei Pharmaceutical Co. Ltd. These companies and their latest proceedings have been tracked by MRFR for a better understanding of the market growth impacts and maps.

Industry News:

In March 2020, researches revealed that opioids are more harmful when it comes to treating patients with kidney diseases than non-steroidal anti-inflammatory drugs (NSAID). In a study of the Chronic Renal Insufficiency Cohort (CRIC) study, researchers realized that the impact of the medicines is quite negative on patients than on people who are not taking opioids. This will give pharmaceutical companies a new direction to work on.

Porcine Vaccines Market : Market Segments, Dynamics, Size, Supply & Demand, Current Trends and Forecast 2023

Porcine Vaccines Market Research Report: by Type (Inactivated Vaccines, DNA Vaccines), by Disease Indication (Diarrhea, Swine Influenza), By End User - Global Forecast Till 2023

Porcine vaccines are drugs administered to swine for protecting them against deadly pathogens and virus strains. The vaccines contain an inactivated form of the virus which can prompt a response from the immunity system and protect it against future infections. The global Porcine Vaccines Market report compiled by Market Research Future (MRFR) contains the various developments of vaccines and the future prospects of the vaccines during the period of 2018 to 2023 (forecast period).

Market Scope
The global porcine vaccines market is touted to expand at 7.1% CAGR over the forecast period. Rising number of swine diseases is the primary driver of the market. African swine fever (ASF) is a recent outbreak which has spread throughout the European Union (EU) and Asia. Major drivers of the market include demand for porcine meat, rising number of biotechnology companies, rise in funding of vaccines by research and development institutes, and inflow of capital to the animal husbandry sector.
But the high storage cost of vaccines can hamper the market growth.

Segmentation
The global porcine vaccines market has been segmented into type, disease indication, and end user.
By type, the market has been segmented into live attenuated vaccines, inactivated vaccines, DNA vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. Toxoid vaccines are inactivated vaccines containing toxins whose genetic structure has been modified to assist in responding actively to threats of viruses.
On the basis of disease indication, the market has been segmented into Aujeszky's disease (AD), swine influenza, PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Porcine Circovirus Associated Disease (PCVAD), and others. PCVAD is a single strand virus which replaces autonomously in eukaryotic cells.
The market, by end user, has been divided into veterinary hospitals and hog production farm.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/7438

Regional Analysis
The global porcine vaccines market has been segmented, by region, into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas will dominate the market owing to high consumption of pig meat and incidence of swine diseases. The rise in contract farming and independent farming for pig cultivation can drive the regional market growth. According to the National Hog Farmer, close to 71.7 million pigs were cultivated in farms in 2016. The development of gelatin based vaccines to prevent the vaccine viruses from external climatic conditions.
Europe held the second position in the market owing to large volumes of consumption of pig meat and recent spate of pig diseases. Awareness created of swine diseases in the EU as well as prevention measures to cull infected wild boars and pigs can drive the regional porcine vaccines market growth.
APAC is predicted to deliver the fastest growth during the forecast period owing to the large population and cultivation of pigs for exports. China, Cambodia, Laos, Australia, and Japan are the biggest contributors of the region. Recombinant DNA vaccines are administered to piglets to induce immune responses in their systems. The expression of IL-18 and M proteins in the body can enhance the potency of the vaccines.
Lastly, the MEA region can account for the lowest share of the global porcine vaccines market owing to efforts taken by governments to promote betterment of animal health. Labeling of halal ingredients used in the vaccine and acceptance of antigens by religious leaders for its mass production can drive the market demand in the region.

Competitive Outlook
Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim International GmbH, Sanofi S.A., Ceva Sante Animale, Zoetis, Inc., Eli Lilly and Company, Aptimmune, Bimeda, Inc., Bayer AG, and PBS Animal Health are key players of the global porcine vaccines market.

Heart Failure Drugs Market 2019-2025: Market Opportunities, Competitive Landscape, Segmentation, Analysis & Forecast

Global Heart Failure Drugs Market: Information by Type (Beta-Blockers, ACE Inhibitors, Angiotensin-Receptor Neprilysin Inhibitors (ARNI), Angiotensin Receptor Blockers (ARBs), Diuretic, Others), End-User (Hospitals, Specialty Centers and others) and Region (Americas, Europe, Asia-Pacific & Middle East & Africa) - Forecast till 2025

Market Highlights
Global Heart Failure Drugs Market is estimated to be valued at USD 13,069.75 Million by 2025 and is expected to register a CAGR of 17.79% during the forecast period.
Heart failure is a chronic condition in which the heart muscle is unable to pump enough blood to the body’s need for blood and oxygen. This results in fatigue and shortness of breath and sometimes results in a cough. Factors such as rising cases of cardiovascular disorders, increasing geriatric population, and the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure are driving the market growth. Additionally, a strong pipeline and product approvals are also driving the market growth. However, serious side-effects hamper the growth of the market.
Segment Analysis
Global Heart Failure Drugs Market has been segmented on the basis of Type, and End User. The market, based on type, has been segmented into Beta-Blockers, ACE Inhibitors, Angiotensin-Receptor Neprilysin Inhibitors (ARNI), Angiotensin Receptor Blockers (ARBs), Diuretic, and others. The global heart failure drugs market, by end-user, has been categorized as hospitals, specialty centers, and others.
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/8760
Regional Analysis
Geographically, the global heart failure drugs market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, the Americas was the largest market for heart failure drugs in 2018 and is expected to remain dominant during the review period. The high prevalence rate of cardiovascular disorders and the constantly changing lifestyle habits such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity are boosting the market growth in the American region. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men and women in the US. CDC also stated that coronary heart disease is the most common type of heart disease, killing 365,914 people in 2017.
Europe would follow the Americas in terms of value during the forecast period owing to the presence of favorable government initiatives and laws, and target population base, and the rising prevalence of lifestyle-associated conditions. For instance, according to the European Heart Journal, overall CVD is estimated to cost the EU economy EUR 210 billion a year, and CVD accounted for over 126 million hospital bed days in the EU, representing 277 hospital bed days per 1000 population.
Asia-Pacific is expected to exhibit the fastest market growth from 2019 to 2025 owing to the increasing per capita health spending, growing older population base, developing the healthcare sector in China, India, and Australia, a defined regulatory framework enabling accelerated product approvals, and diagnostic process at comparatively lower prices.
The Middle East and Africa are expected to represent a modest market growth from 2019 to 2025. The Middle East would hold a substantial market share over the assessment period due to increasing obesity issues, rising initiatives by governments to improve patient care, and favorable reimbursement policies

Key Players
Market Research Future (MRFR) recognizes Amgen Inc. (US), AstraZeneca (UK), Novartis AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson Services, Inc. (UK), Bristol-Myers Squibb Company (US), Merck Sharp & Dohme Corp. (US), Pfizer, Inc. (US), and Gilead Sciences, Inc. (California) as the Key Players in the Global Heart Failure Drugs Market.
Key Findings of the Study

The Global Heart Failure Drugs Market is projected to reach over USD 13,069.75 Million by 2025 at a 79% CAGR during the review period of 2019 to 2025.

The US held a market share of 79.1% in 2018. Initiatives of major players and rising cardiovascular cases are driving the market growth. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men and women in the US.

Based on type, the Angiotensin Receptor Neprilysin Inhibitors segment accounted for the largest market share of 31.6% in 2018.

On the basis of end-user, the specialty centers segment accounted for the largest market share of 38.4% in 2018.

Thursday, May 28, 2020

Nebulizers Market: Historical, Current and Projected Market Size, Competitive landscape & Forecast 2027

Global Nebulizers Market: By Type (Mesh, Jet, Ultrasonic), Usage (Reusable, Disposable), by Portability (Tabletop, Portable), End User (Hospitals and Clinics, Homecare, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

Market Highlights
According to MRFR analysis, the Global Nebulizers Market is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027.
A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine.
The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19.
Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period.
However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market.
Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients.

Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/9586

Segmentation
The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User.
Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers.
On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users.
Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use.

The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players
Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).

Breast Lesion Localization Market Covering Competitive Scenario & Market Dynamics throughout 2025

Global Breast Lesion Localization Market Research Report, by Type (Wire-Guided Localization, Radioactive Seed Localization, Non-Radioactive Radar Localization, and Magnetic Seed), Usage (Tumor Identification and Sentinel Lymph Node Identification), End User (Hospitals and Clinics and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2025

Market Highlights
According to MRFR analysis, Global Breast Lesion Localization Market is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 560 Million by 2025.
The growth of the global breast lesion localization market is driven by various factors, such as the increasing launch of breast lesion localization products and growing numbers of players involved in the development of new breast lesion localization technologies. Some of the key companies operating in this market are B.D. Company, Cook Medical, Endomagnetics Ltd, and others. In addition, the rising awareness program related to breast cancer supports the market growth during the forecasted period.
However, the lack of skilled professionals and the cost of breast lesion localization products may hamper market growth.

Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to a large number of men and women affected by breast cancer. The breast lesion localization market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The adaption of a sedentary lifestyle, high consumption of alcohol is leading to cause various types of cancer in which breast cancer holds a high position. It is estimated that 2,620 new cases of breast cancer are anticipated to be diagnosed in men in 2020 in the US. The increasing population affected by breast cancer drives the market growth.
The European breast lesion localization market is the fastest-growing market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing healthcare expenditure, presence of medical device companies, and acceptance of new diagnostic products by diagnostic centers pushing the growth of the regional market. The breast lesion localization market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, rising per capita income, growing healthcare expenditure and awareness towards the diagnosis of breast cancer drives the market to grow at a significant rate during the forecast. The breast lesion localization market in the Middle East & Africa has been divided into the Middle East and Africa.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/8785

Segmentation
The Global Breast Lesion Localization Market has been segmented based on Type, Technique, Usage, and End Users.
The global breast lesion localization market has been segmented, on the basis of type, into wire-guided localization, radioactive seed localization, non-radioactive radar localization, magnetic seed, and others. The wire-guided localization segment is expected to hold the maximum share of the market throughout the forecast period. The magnetic seed segment is expected to be the fastest-growing during the assessment period. On the basis of technique, the market is segmented into fine-needle aspiration biopsy, core needle biopsy, and image-guided biopsy. Based on usage, the market is segmented into tumor identification and sentinel lymph node identification. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers and diagnostic centers.

Key Players
Some of the key players in the Global Breast Lesion Localization Market are B.D. Company (US), Cianna Medical (US), Cook Medical (US), Endomagnetics Ltd (UK), Health Beacon (Ireland), Intramedicalimaging, Devicor Medical Products, Inc (US), Somatex Medical Technologies GmbH (Germany), Surgiceye GmbH (Germany) and Ranfac Corporation (US).

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.